World's Best Scientists 2026 revealed!
Bengt Glimelius

Bengt Glimelius

Award Badge
Medicine
Sweden
2023

D-Index & Metrics

Medicine

D-Index
144
Citations
103195
World Ranking
1413
National Ranking
30

Research.com Recognitions

  • 2023 - Research.com Medicine in Sweden Leader Award

Overview

Bengt Glimelius is a researcher affiliated with Uppsala University in Sweden, specializing in medicine with a focus on oncology and colorectal cancer. Their work encompasses various aspects of colorectal cancer treatments, surgical interventions, screening, and genetic factors, alongside broader interests in cancer genomics and diagnostics as well as gastric cancer management.

Their research portfolio includes numerous publications in prominent venues with a significant number appearing in the following journals:

  • Annals of Oncology
  • Cancers
  • Journal of Clinical Oncology
  • Radiotherapy and Oncology
  • UNC Libraries

Glimelius' recent influential papers demonstrate a concentration on rectal and colon cancer treatment methods. Selected recent publications include:

  • "Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial" (2020) published in The Lancet Oncology
  • "Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial" (2023) in Journal of Clinical Oncology
  • "Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery" (2023) in Annals of Surgery
  • "Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial" (2020) in Radiotherapy and Oncology
  • "Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study" (2023) in Cancer Cell

The scientist frequently collaborates with several co-authors who have contributed alongside in numerous publications. These include:

  • Tobias Sjöblom
  • Per J. Nilsson
  • Per Pfeiffer
  • Pia Österlund
  • Corrie A.M. Marijnen

In terms of academic fields, the main area of study is medicine, with a more refined focus on:

  • Oncology
  • Surgery
  • Pathology and Forensic Medicine
  • Pulmonary and Respiratory Medicine
  • Cancer Research

The dominant topics covered in Bengt Glimelius's research include colorectal cancer treatments and studies, colorectal cancer surgical treatments, colorectal and anal carcinomas, colorectal cancer screening and detection, genetic factors in colorectal cancer, gastric cancer management and outcomes, and cancer genomics and diagnostics.

Best Publications

  • Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer

    Ellen Kapiteijn;Corrie A.M. Marijnen;Iris D. Nagtegaal;Hein Putter

  • A pathology atlas of the human cancer transcriptome

    Mathias Uhlen;Mathias Uhlen;Cheng Zhang;Sunjae Lee;Evelina Sjöstedt;Evelina Sjöstedt

  • Improved survival with preoperative radiotherapy in resectable rectal cancer.

    B Cedermark;M Dahlberg;B Glimelius

  • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Bengt Glimelius;Graeme J Poston

  • Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

    John P. Neoptolemos;John P. Neoptolemos;Daniel H. Palmer;Daniel H. Palmer;Paula Ghaneh;Eftychia E. Psarelli

  • Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

    Willem van Gijn;Carrie A. M. Marijnen;Iris D. Nagtegaal;Elma Meershoek-Klein Kranenbarg

  • ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    H J Schmoll;E Van Cutsem;A Stein;V Valentini

  • Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Bengt Glimelius;Lars Påhlman;A. Cervantes

  • Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983) : long-term results of a randomised, controlled, phase 3 trial

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston

  • The TME Trial After a Median Follow-Up of 6 Years: Increased Local Control but No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma

    Koen C. M. J. Peeters;Corrie A. M. Marijnen;Iris D. Nagtegaal;Elma Klein Kranenbarg

  • Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer

    B Glimelius;K Ekström;K Hoffman;W Graf

  • Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib the LAP07 randomized clinical trial

    Pascal Hammel;Florence Huguet;Jean-Luc van Laethem;David Goldstein

  • Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.

    Renu R Bahadoer;Esmée A Dijkstra;Boudewijn van Etten;Corrie A M Marijnen;Corrie A M Marijnen

  • Swedish rectal cancer trial : Long lasting benefits from radiotherapy on survival and local recurrence rate

    Joakim Folkesson;Helgi Birgisson;Lars Pahlman;Bjorn Cedermark

  • Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

    B Glimelius;Katarina Hoffman;P-O Sjoden;G Jacobsson

  • Sexually Transmitted Infection as a Cause of Anal Cancer

    Frisch M;Glimelius B;van den Brule Aj;Wohlfahrt J

  • Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial.

    Lars Påhlman;Bengt Glimelius

  • Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

    Richard Herrmann;György Bodoky;Thomas Ruhstaller;Bengt Glimelius

  • DUTCH COLORECTAL CANCER GROUP. PREOPERATIVE RADIOTHERAPY COMBINED WITH TOTAL MESORECTAL EXCISION FOR RESECTABLE RECTAL CANCER

    E Kapiteijn;C A Marijnen;I D Nagtegaal;H Putter

  • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983)

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston

Frequent Co-Authors

Lars Påhlman
Lars Påhlman Uppsala University
Hans-Olov Adami
Hans-Olov Adami Karolinska Institute
Mads Melbye
Mads Melbye University of Copenhagen
Peter Nygren
Peter Nygren Uppsala University
Karin E. Smedby
Karin E. Smedby Karolinska University Hospital
Henrik Hjalgrim
Henrik Hjalgrim Statens Serum Institut
Christer Sundström
Christer Sundström Uppsala University
David Cunningham
David Cunningham Royal Marsden NHS Foundation Trust
Ellen T. Chang
Ellen T. Chang Stanford University
Angela Brooks-Wilson
Angela Brooks-Wilson Simon Fraser University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean medical school. There are several respected online degrees that open doors within the healthcare field. These programs are ideal for those who want to play a critical role in healthcare while balancing studies with work or family commitments.

If you’re interested in leadership roles, consider a healthcare administration degree online. This program teaches management, policy, and organizational skills. For advanced positions, you might research the most affordable online mha programs, which offer specialized expertise at the graduate level.

Nursing professionals wanting to impact patient care can look into cheap dnp online programs. A Doctor of Nursing Practice prepares you for leadership or clinical roles with a flexible online format. Pharmacists can boost their qualifications through an online pharmd degree, tailored for career advancement or specialized practice.

These pathways provide affordable and flexible alternatives to traditional on-campus degrees, supporting a variety of rewarding healthcare careers beyond medicine itself.

Best Scientists Citing Bengt Glimelius

Trending Scientists

Recently Published Articles